386 related articles for article (PubMed ID: 32114479)
21. A self-management programme to reduce falls and improve safe mobility in people with secondary progressive MS: the BRiMS feasibility RCT.
Gunn H; Andrade J; Paul L; Miller L; Creanor S; Stevens K; Green C; Ewings P; Barton A; Berrow M; Vickery J; Marshall B; Zajicek J; Freeman J
Health Technol Assess; 2019 Jun; 23(27):1-166. PubMed ID: 31217069
[TBL] [Abstract][Full Text] [Related]
22. Evaluating Acupuncture and Standard carE for pregnant women with Back pain (EASE Back): a feasibility study and pilot randomised trial.
Foster NE; Bishop A; Bartlam B; Ogollah R; Barlas P; Holden M; Ismail K; Jowett S; Kettle C; Kigozi J; Lewis M; Lloyd A; Waterfield J; Young J
Health Technol Assess; 2016 Apr; 20(33):1-236. PubMed ID: 27133814
[TBL] [Abstract][Full Text] [Related]
23. Survival Outcomes in Patients With Previously Untreated BRAF Wild-Type Advanced Melanoma Treated With Nivolumab Therapy: Three-Year Follow-up of a Randomized Phase 3 Trial.
Ascierto PA; Long GV; Robert C; Brady B; Dutriaux C; Di Giacomo AM; Mortier L; Hassel JC; Rutkowski P; McNeil C; Kalinka-Warzocha E; Savage KJ; Hernberg MM; Lebbé C; Charles J; Mihalcioiu C; Chiarion-Sileni V; Mauch C; Cognetti F; Ny L; Arance A; Svane IM; Schadendorf D; Gogas H; Saci A; Jiang J; Rizzo J; Atkinson V
JAMA Oncol; 2019 Feb; 5(2):187-194. PubMed ID: 30422243
[TBL] [Abstract][Full Text] [Related]
24. Immune Checkpoint Inhibitors and Immune-Related Adverse Events in Patients With Advanced Melanoma: A Systematic Review and Network Meta-analysis.
Chang CY; Park H; Malone DC; Wang CY; Wilson DL; Yeh YM; Van Boemmel-Wegmann S; Lo-Ciganic WH
JAMA Netw Open; 2020 Mar; 3(3):e201611. PubMed ID: 32211869
[TBL] [Abstract][Full Text] [Related]
25. Visually Impaired OLder people's Exercise programme for falls prevenTion (VIOLET): a feasibility study protocol.
Skelton DA; Bailey C; Howel D; Cattan M; Deary V; Coe D; de Jong LD; Gawler S; Gray J; Lampitt R; Wilkinson J; Adams N
BMJ Open; 2016 Aug; 6(8):e011996. PubMed ID: 27486124
[TBL] [Abstract][Full Text] [Related]
26. Using a cancer registry to capture signals of adverse events following immune and targeted therapy for melanoma.
Aguiar JP; Cardoso Borges F; Murteira R; Ramos C; Gouveia E; Passos MJ; Miranda A; da Costa FA
Int J Clin Pharm; 2018 Aug; 40(4):852-861. PubMed ID: 29860707
[TBL] [Abstract][Full Text] [Related]
27. 'Pragmatic randomized controlled trial of individually prescribed exercise versus usual care in a heterogeneous cancer survivor population': a feasibility study PEACH trial: prescribed exercise after chemotherapy.
Walsh JM; Hussey J; Guinan E; O' Donnell D
BMC Cancer; 2010 Feb; 10():42. PubMed ID: 20156345
[TBL] [Abstract][Full Text] [Related]
28. PATHway I: design and rationale for the investigation of the feasibility, clinical effectiveness and cost-effectiveness of a technology-enabled cardiac rehabilitation platform.
Claes J; Buys R; Woods C; Briggs A; Geue C; Aitken M; Moyna N; Moran K; McCaffrey N; Chouvarda I; Walsh D; Budts W; Filos D; Triantafyllidis A; Maglaveras N; Cornelissen VA
BMJ Open; 2017 Jun; 7(6):e016781. PubMed ID: 28667228
[TBL] [Abstract][Full Text] [Related]
29. Active Treatment for Idiopathic Adolescent Scoliosis (ACTIvATeS): a feasibility study.
Williams MA; Heine PJ; Williamson EM; Toye F; Dritsaki M; Petrou S; Crossman R; Lall R; Barker KL; Fairbank J; Harding I; Gardner A; Slowther AM; Coulson N; Lamb SE
Health Technol Assess; 2015 Jul; 19(55):1-242. PubMed ID: 26200118
[TBL] [Abstract][Full Text] [Related]
30. PERCEPT myeloma: a protocol for a pilot randomised controlled trial of exercise prehabilitation before and during autologous stem cell transplantation in patients with multiple myeloma.
McCourt O; Fisher A; Ramdharry G; Roberts AL; Land J; Rabin N; Yong K
BMJ Open; 2020 Jan; 10(1):e033176. PubMed ID: 32001493
[TBL] [Abstract][Full Text] [Related]
31. Final analysis of a randomised trial comparing pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory advanced melanoma.
Hamid O; Puzanov I; Dummer R; Schachter J; Daud A; Schadendorf D; Blank C; Cranmer LD; Robert C; Pavlick AC; Gonzalez R; Hodi FS; Ascierto PA; Salama AKS; Margolin KA; Gangadhar TC; Wei Z; Ebbinghaus S; Ibrahim N; Ribas A
Eur J Cancer; 2017 Nov; 86():37-45. PubMed ID: 28961465
[TBL] [Abstract][Full Text] [Related]
32. Protocol for a pilot randomised controlled trial of an online intervention for post-treatment cancer survivors with persistent fatigue.
Corbett T; Walsh JC; Groarke A; Moss-Morris R; McGuire BE
BMJ Open; 2016 Jun; 6(6):e011485. PubMed ID: 27288384
[TBL] [Abstract][Full Text] [Related]
33. Improving Mood with Physical ACTivity (IMPACT) trial: a cluster randomised controlled trial to determine the effectiveness of a brief physical activity behaviour change intervention on depressive symptoms in young people, compared with psychoeducation, in addition to routine clinical care within youth mental health services-a protocol study.
Parker AG; Markulev C; Rickwood DJ; Mackinnon A; Purcell R; Alvarez-Jimenez M; Yung AR; McGorry P; Hetrick SE; Jorm A
BMJ Open; 2019 Oct; 9(10):e034002. PubMed ID: 31662409
[TBL] [Abstract][Full Text] [Related]
34. Effect of acute aerobic exercise before immunotherapy and chemotherapy infusion in patients with metastatic non-small-cell lung cancer: protocol for the ERICA feasibility trial.
Gouez M; Pérol O; Pérol M; Caux C; Ménétrier-Caux C; Villard M; Walzer T; Delrieu L; Saintigny P; Marijnen P; Pialoux V; Fervers B
BMJ Open; 2022 Apr; 12(4):e056819. PubMed ID: 35393316
[TBL] [Abstract][Full Text] [Related]
35. Changing physical activity behaviour for people with multiple sclerosis: protocol of a randomised controlled feasibility trial (iStep-MS).
Ryan JM; Fortune J; Stennett A; Kilbride C; Anokye N; Victor C; Hendrie W; Abdul M; DeSouza L; Lavelle G; Brewin D; David L; Norris M
BMJ Open; 2017 Nov; 7(11):e018875. PubMed ID: 29146660
[TBL] [Abstract][Full Text] [Related]
36. Connected device and therapeutic patient education to promote physical activity among women with localised breast cancer (DISCO trial): protocol for a multicentre 2×2 factorial randomised controlled trial.
Touillaud M; Fournier B; Pérol O; Delrieu L; Maire A; Belladame E; Pérol D; Perrier L; Preau M; Leroy T; Fassier JB; Fillol F; Pascal S; Durand T; Fervers B
BMJ Open; 2021 Sep; 11(9):e045448. PubMed ID: 34518245
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of nivolumab in combination with ipilimumab in Japanese patients with advanced melanoma: An open-label, single-arm, multicentre phase II study.
Namikawa K; Kiyohara Y; Takenouchi T; Uhara H; Uchi H; Yoshikawa S; Takatsuka S; Koga H; Wada N; Minami H; Hatsumichi M; Asada S; Namba Y; Yamazaki N
Eur J Cancer; 2018 Dec; 105():114-126. PubMed ID: 30447539
[TBL] [Abstract][Full Text] [Related]
38. Feasibility of supervised telehealth exercise for patients with advanced melanoma receiving checkpoint inhibitor therapy.
Crosby BJ; Newton RU; Galvão DA; Taaffe DR; Lopez P; Meniawy TM; Khattak MA; Lam WS; Gray ES; Singh F
Cancer Med; 2023 Jul; 12(13):14694-14706. PubMed ID: 37184115
[TBL] [Abstract][Full Text] [Related]
39. Protocol for a pragmatic randomised controlled feasibility study of
van der Mei I; Thomas S; Shapland S; Laslett LL; Taylor BV; Huglo A; Honan C
BMJ Open; 2024 May; 14(5):e079644. PubMed ID: 38772578
[TBL] [Abstract][Full Text] [Related]
40. Randomised controlled trial of a supervised exercise rehabilitation program for colorectal cancer survivors immediately after chemotherapy: study protocol.
Spence RR; Heesch KC; Eakin EG; Brown WJ
BMC Cancer; 2007 Aug; 7():154. PubMed ID: 17686184
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
